English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe results of a new brain imaging study led by researchers at Stony Brook Medicine indicates a link between World Trade Center (WTC) exposure duration and the presence of amyloid in the brain. The findings are published in the Journal of Alzheimer’s Disease.
Tag: Alzheimer’s disease
Rutgers Institute Celebrates 10 Years of Advancing Neuroscience and Brain Health Research
Members of the Brain Health Institute at Rutgers mark a decade of innovation with an awards ceremony honoring faculty
November Research Tip Sheet
Cedars-Sinai has published a summary highlighting its research advances for November 2024.
MSU researchers receive $4M NIH grant to study dementia risks
MSU researchers receive $4M NIH grant to study dementia risks
New award advances Sanders-Brown director’s research on inflammation’s role in Alzheimer’s
The University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., hopes to shed light on how specific brain cells may contribute to the progression of Alzheimer’s disease, paving the way for potential new therapeutic approaches.Van Eldik recently received a three-year, $300,000 award from the BrightFocus Foundation to support her research project, “Relationship between astrocyte p38 MAPK, neuroinflammation, and Alzheimer pathology.
UW–Madison researchers find persistent problems with AI-assisted genomic studies
University of Wisconsin–Madison researchers are warning that artificial intelligence tools gaining popularity in the fields of genetics and medicine can lead to flawed conclusions about the connection between genes and physical characteristics, including risk factors for diseases like diabetes.The faulty predictions are linked to researchers’ use of AI to assist genome-wide association studies.
Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston
Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).
Addressing Alzheimer’s in American Indian communities
This $11 million IHS contract will create training for healthcare providers and support patients’ families in communities that have little access to such specialized care.
Patterns of Intelligence
The coordinated activity of brain cells, like birds flying in formation, helps us behave intelligently in new situations, according to a study led by Cedars-Sinai investigators.
Expert on Alzheimer’s Therapeutic Development AAIC 2024
Our grant proprosal is to identify how two protective mechanisms work and then test them in both European and Amerindian APOE4 genes to see if they work in those genetic backgrounds as well as African.
Pilot Study Provides ‘Blueprint’ for Evaluating Diet’s Effect on Brain Health
Researchers from Johns Hopkins Medicine and the National Institutes of Health’s National Institute on Aging say their study of 40 older adults with obesity and insulin resistance who were randomly assigned to either an intermittent fasting diet or a standard healthy diet approved by the U.S. Department of Agriculture (USDA) offers important clues about the potential benefits of both eating plans on brain health.
Mount Sinai Experts Present Research at SLEEP 2024
Sleep medicine experts available for interview on breaking and trending news about obstructive sleep apnea, CPAP, and more
Earlier Menopause Plus High Cardiovascular Risk May Lead to Cognitive Problems Later
Earlier menopause combined with higher risk of cardiovascular disease is linked to an increased risk of thinking and memory problems later, according to a new study published in the April 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. In this study, earlier menopause is defined as occurring before age 49.
Do Veterans Who Experience Concussions Have an Increased Risk of Alzheimer’s?
Middle-age veterans who experienced concussions due to blasts from explosive devices may have biomarkers in their spinal fluid similar to people who develop Alzheimer’s disease, according to a new study published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers make precious headway into a genetic form of Alzheimer’s disease
UC Santa Barbara researchers and collaborators in Colombia, Brazil and Germany are progressing toward an understanding of mechanisms that underlie Alzheimer’s disease, in particular an early-onset, genetic form that has afflicted generations of an extended family in Colombia.
New genetic therapy holds promise for ALS and frontotemporal dementia
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.
Erectile Dysfunction Drugs May Be Linked to Reduced Risk of Alzheimer’s Disease
The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Nicolas Musi, MD, Named Inaugural Cypres Chair in Diabetes Research
Nicolas Musi, MD, studies a spectrum of age-related disorders that can impact a healthy lifespan.
Number of dementia cases could be 42% higher than previously estimated by 2040
Up to 1.7 million people could be living with dementia in England and Wales by 2040 – over 40% more than previously forecast – finds a new UCL-led study.
Study indicates possible link between chronic stress and Alzheimer’s disease
Researchers from Karolinska Institutet have published a study in Alzheimer’s Research & Therapy that addresses possible associations between chronic stress, mild cognitive impairment and Alzheimer’s disease.
A fitness tracker for brain health: How a headband can identify early signs of Alzheimer’s disease in your sleep
Researchers have identified a way to assess brain activity in sleep that occurs in the earliest stages of Alzheimer’s disease, typically many years prior to developing symptoms of dementia.
Can a Blood Test Detect Alzheimer’s Disease?
In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market.
Small Percentage of People with Early Dementia Eligible for New Alzheimer’s Drugs
Only a small percentage of older adults who are in the early stages of Alzheimer’s disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an early sign of Alzheimer’s disease. The new research is published in the August 16, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. Clinical trial results for these drugs are only available in people in the early symptomatic stages of the disease, mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Eat your vegetables to protect your brain
A new study published in the Journal of Alzheimer’s Disease by a Virginia Tech Carilion School of Medicine faculty member shows that brain levels of dietary lutein, zeaxanthin, lycopene, and vitamin E in those with Alzheimer’s disease are half those in normal brains. Higher dietary levels of lutein and zeaxanthin have been strongly linked to better cognitive functions and lower risk for dementia or Alzheimer’s disease.
New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease
A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD). This study focused on a protein known as p38.
‘Fastball’ test to detect Alzheimer’s earlier gets major £1.5 million funding boost
A simple but revolutionary test to improve early detection for dementia and Alzheimer’s disease could soon be helping patients and their families, thanks to a significant £1.5 million funding boost awarded to the universities of Bath and Bristol.
Stem cell model of human brain development suggests embryonic origins of Alzheimer’s disease
Alzheimer’s disease (AD) mainly affects the older population. Recent research found early disease signs in cell culture models of early human brain development, raising the possibility that the disease has its origins much earlier in life, possibly during embryogenesis – the formation and development of an embryo.
Mount Sinai Experts Present Research at SLEEP 2023
Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.
Having dementia and reduction in social participation are associated with increased depression and anxiety during the COVID-19 pandemic
An increased risk of depression and anxiety among US older adults with dementia and poor activity participation has been demonstrated through an analysis of data from the National Health and Aging Trends Study (NHATS), a nationally representative population-based study.
Mount Sinai Launches Institute for Regenerative Medicine
Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.
Sugar molecule in blood can predict Alzheimer’s disease
Early diagnosis and treatment of Alzheimer’s disease requires reliable and cost-effective screening methods.
Using radar to predict Alzheimer’s disease and fall accidents
Researchers at Chalmers University of Technology in Sweden have developed a method for predicting fall accidents and cognitive illnesses such as Alzheimer’s disease by reading a person’s walking pattern with the aid of a radar sensor.
In patients with mild cognitive impairment, apathy can be a predictor of Alzheimer’s disease
The presence of apathy in patients with mild cognitive impairment is strongly linked to a progression to Alzheimer’s disease, giving physicians a possible early diagnosis tool, according to UTHealth Houston research published recently in the Journal of Alzheimer’s Disease.
$11M NIH Grant Will Support Evaluation of Alzheimer’s Screening Tool in Primary Care Settings
Investigators at Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and Indiana University School of Medicine have received an $11 million grant from the National Institutes of Health (NIH) to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.
Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease
Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing user-friendly health information tools and technology designed to enhance accessibility and value to older adults with both diabetes and Alzheimer’s disease, and their caregivers.
Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive Disorders
Deep learning models represent “an entirely new paradigm for studying dementia”
Mayo Clinic expert provides tips for reducing dementia risk
More than 55 million people worldwide are believed to be living with dementia, according to the World Health Organization. Ronald Petersen, M.D., a neurologist and director of Mayo Clinic’s Alzheimer’s Disease Research Center, says you can’t prevent dementia, but you can reduce your risk.
Early Alzheimer’s detection up to 17 years in advance
The dementia disorder Alzheimer’s disease has a symptom-free course of 15 to 20 years before the first clinical symptoms emerge.
Investigational test may detect Alzheimer’s disease at early stages
Currently, the only accurate diagnosis of Alzheimer’s disease is through postmortem analyses after a patient dies, but investigators have now developed a highly sensitive method for quantifying levels of tau protein—a hallmark of the condition—in cerebrospinal fluid surrounding the brain and spinal cord.
Study Finds Untreated Sleep Apnea May Increase Risk for Neurodegenerative Disease, PAP Therapies Crucial in Treating the Sleep Condition
Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer’s disease biomarkers from blood.
UCI wins 5-year, $14M NIH grant to study brain circuits susceptible to aging, Alzheimer’s disease
Irvine, Calif., June 7, 2022 — The University of California, Irvine has been awarded a five-year, $14 million grant from the National Institutes of Health to study brain circuits that are susceptible to aging and Alzheimer’s disease. The research findings will advance the development of early diagnostic tools and the discovery of new treatment strategies.
KTU Researchers Investigate the Links Between Facial Recognition and Alzheimer’s Disease
In recent years Alzheimer’s disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled.
Single-cell DNA sequencing offers a new angle on the causes of Alzheimer’s disease
Alzheimer’s disease is marked by a loss of functional neurons in the brain.
Genetic changes differed, increased in people with Alzheimer’s disease
Inside brain cells, errors in DNA can accumulate as we age. But in patients with Alzheimer’s disease, these errors — known as somatic mutations — may build up at a faster rate.
Interferon drives cognitive impairment in Alzheimer’s disease model
Alzheimer’s disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new things and accomplish everyday activities.
Hope Builds for New Therapeutics to Reverse or Prevent Alzheimer’s
A new study from the University of Mississippi Medical Center in Jackson finds that (Aβ) accumulation in AD is associated with reduced blood flow to the brain, known as cerebral hypoperfusion.
Combination of biomarkers can identify common cognitive disease
In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis.
On repeat: Listening to favorite music improves brain plasticity, cognitive performance of Alzheimer’s patients, Toronto researchers find
Researchers at the University of Toronto (U of T) and Unity Health Toronto have demonstrated that repeated listening to personally meaningful music induces beneficial brain plasticity in patients with mild cognitive impairment or early Alzheimer’s disease.
New brain model provides patient-specific Alzheimer’s insights, predictions of cognitive decline
A study led by researchers from Brigham and Women’s Hospital has established a new resource for exploring and understanding Alzheimer’s disease (AD) on an individualized level.
Recent Study Identifies 11 Candidate Genetic Variants for Alzheimer’s Disease
A recently published study co-authored by University of Kentucky Sanders-Brown Center on Aging researcher Justin Miller, Ph.D., identifies 11 rare candidate variants for Alzheimer’s disease. Researchers found 19 different families in Utah that suffered from Alzheimer’s disease more frequently than what is considered normal.